1142 related articles for article (PubMed ID: 29045505)
41. Liquid Biopsy for Pancreatic Cancer by Serum Extracellular Vesicle-Encapsulated Long Noncoding RNA HEVEPA.
Takahashi K; Inuzuka T; Shimizu Y; Sawamoto K; Taniue K; Ono Y; Asai F; Koyama K; Sato H; Kawabata H; Iwamoto H; Yamakita K; Kitano Y; Teramoto T; Fujiya M; Fujii S; Mizukami Y; Okumura T
Pancreas; 2024 May; 53(5):e395-e404. PubMed ID: 38416857
[TBL] [Abstract][Full Text] [Related]
42. Combining Machine Learning and Nanofluidic Technology To Diagnose Pancreatic Cancer Using Exosomes.
Ko J; Bhagwat N; Yee SS; Ortiz N; Sahmoud A; Black T; Aiello NM; McKenzie L; O'Hara M; Redlinger C; Romeo J; Carpenter EL; Stanger BZ; Issadore D
ACS Nano; 2017 Nov; 11(11):11182-11193. PubMed ID: 29019651
[TBL] [Abstract][Full Text] [Related]
43. Next-Generation Sequencing in Pancreatic Cancer.
Shen GQ; Aleassa EM; Walsh RM; Morris-Stiff G
Pancreas; 2019 Jul; 48(6):739-748. PubMed ID: 31206465
[TBL] [Abstract][Full Text] [Related]
44. An elevated expression of serum exosomal microRNA-191, - 21, -451a of pancreatic neoplasm is considered to be efficient diagnostic marker.
Goto T; Fujiya M; Konishi H; Sasajima J; Fujibayashi S; Hayashi A; Utsumi T; Sato H; Iwama T; Ijiri M; Sakatani A; Tanaka K; Nomura Y; Ueno N; Kashima S; Moriichi K; Mizukami Y; Kohgo Y; Okumura T
BMC Cancer; 2018 Jan; 18(1):116. PubMed ID: 29385987
[TBL] [Abstract][Full Text] [Related]
45. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.
Hocker JR; Postier RG; Li M; Lerner MR; Lightfoot SA; Peyton MD; Deb SJ; Baker CM; Williams TL; Hanas RJ; Stowell DE; Lander TJ; Brackett DJ; Hanas JS
Cancer Lett; 2015 Apr; 359(2):314-24. PubMed ID: 25637792
[TBL] [Abstract][Full Text] [Related]
46. c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer.
Lux A; Kahlert C; Grützmann R; Pilarsky C
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284422
[TBL] [Abstract][Full Text] [Related]
47. Prognostic Implications of Multiplex Detection of
Kim MK; Woo SM; Park B; Yoon KA; Kim YH; Joo J; Lee WJ; Han SS; Park SJ; Kong SY
Clin Chem; 2018 Apr; 64(4):726-734. PubMed ID: 29352043
[TBL] [Abstract][Full Text] [Related]
48. Untargeted LC-HRMS-Based Metabolomics for Searching New Biomarkers of Pancreatic Ductal Adenocarcinoma: A Pilot Study.
Ríos Peces S; Díaz Navarro C; Márquez López C; Caba O; Jiménez-Luna C; Melguizo C; Prados JC; Genilloud O; Vicente Pérez F; Pérez Del Palacio J
SLAS Discov; 2017 Apr; 22(4):348-359. PubMed ID: 27655283
[TBL] [Abstract][Full Text] [Related]
49. KRAS mutations in pancreatic circulating tumor cells: a pilot study.
Kulemann B; Liss AS; Warshaw AL; Seifert S; Bronsert P; Glatz T; Pitman MB; Hoeppner J
Tumour Biol; 2016 Jun; 37(6):7547-54. PubMed ID: 26684803
[TBL] [Abstract][Full Text] [Related]
50. Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer.
Mellby LD; Nyberg AP; Johansen JS; Wingren C; Nordestgaard BG; Bojesen SE; Mitchell BL; Sheppard BC; Sears RC; Borrebaeck CAK
J Clin Oncol; 2018 Oct; 36(28):2887-2894. PubMed ID: 30106639
[TBL] [Abstract][Full Text] [Related]
51. Exosomal proteins as potential markers of tumor diagnosis.
Li A; Zhang T; Zheng M; Liu Y; Chen Z
J Hematol Oncol; 2017 Dec; 10(1):175. PubMed ID: 29282096
[TBL] [Abstract][Full Text] [Related]
52. Detection of exosomal biomarker by electric field-induced release and measurement (EFIRM).
Tu M; Wei F; Yang J; Wong D
J Vis Exp; 2015 Jan; (95):52439. PubMed ID: 25650727
[TBL] [Abstract][Full Text] [Related]
53. Utility of liquid biopsy using urine in patients with pancreatic ductal adenocarcinoma.
Terasawa H; Kinugasa H; Ako S; Hirai M; Matsushita H; Uchida D; Tomoda T; Matsumoto K; Horiguchi S; Kato H; Nouso K; Okada H
Cancer Biol Ther; 2019; 20(10):1348-1353. PubMed ID: 31328611
[TBL] [Abstract][Full Text] [Related]
54. Rapid and comprehensive 'shotgun' lipidome profiling of colorectal cancer cell derived exosomes.
Lydic TA; Townsend S; Adda CG; Collins C; Mathivanan S; Reid GE
Methods; 2015 Oct; 87():83-95. PubMed ID: 25907253
[TBL] [Abstract][Full Text] [Related]
55. Detection of phosphatidylserine-positive exosomes for the diagnosis of early-stage malignancies.
Sharma R; Huang X; Brekken RA; Schroit AJ
Br J Cancer; 2017 Aug; 117(4):545-552. PubMed ID: 28641308
[TBL] [Abstract][Full Text] [Related]
56. Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes.
Zhao L; Zhao H; Yan H
BMC Cancer; 2018 May; 18(1):603. PubMed ID: 29843660
[TBL] [Abstract][Full Text] [Related]
57. Exosomal ROR1 in peritoneal fluid identifies peritoneal disseminated PDAC and is associated with poor survival.
Mittelstädt A; Anthuber A; David P; Podolska M; Bénard A; Brunner M; Krautz C; Jacobsen A; Denz A; Weber K; Merkel S; Hackner D; Buniatov T; Roßdeutsch L; Klösch B; Swierzy I; Hansen FJ; Strobel D; Zopf Y; Baur JO; Van Deun J; Immanuel Geppert C; Gießl A; Lettmaier S; Semrau S; Grützmann R; Kouhestani D; Weber GF
Front Immunol; 2024; 15():1253072. PubMed ID: 38846943
[TBL] [Abstract][Full Text] [Related]
58. Role of exosomal proteins in cancer diagnosis.
Li W; Li C; Zhou T; Liu X; Liu X; Li X; Chen D
Mol Cancer; 2017 Aug; 16(1):145. PubMed ID: 28851367
[TBL] [Abstract][Full Text] [Related]
59. Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer.
Hadano N; Murakami Y; Uemura K; Hashimoto Y; Kondo N; Nakagawa N; Sueda T; Hiyama E
Br J Cancer; 2016 Jun; 115(1):59-65. PubMed ID: 27280632
[TBL] [Abstract][Full Text] [Related]
60. Isolation of Biologically Active Exosomes from Plasma of Patients with Cancer.
Hong CS; Funk S; Whiteside TL
Methods Mol Biol; 2017; 1633():257-265. PubMed ID: 28735492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
